GEODE CAPITAL MANAGEMENT, LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$286,163
-9.4%
142,349
-8.5%
0.00%
Q2 2023$315,939
+2.0%
155,6350.0%0.00%
Q1 2023$309,713
+84290.5%
155,6350.0%0.00%
Q4 2022$367
-99.9%
155,635
-0.2%
0.00%
Q3 2022$321,000
+25.4%
155,870
+51.5%
0.00%
Q2 2022$256,000
+15.8%
102,911
+6.8%
0.00%
Q1 2022$221,000
+7.8%
96,326
+1.0%
0.00%
Q4 2021$205,000
-27.3%
95,3580.0%0.00%
Q3 2021$282,000
-7.5%
95,358
+8.8%
0.00%
Q2 2021$305,000
+5.9%
87,659
+10.7%
0.00%
Q1 2021$288,000
+119.8%
79,151
+141.7%
0.00%
Q4 2020$131,00032,7520.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,174,270$2,360,2832.13%
BML Capital Management, LLC 706,930$1,420,9291.30%
Newtyn Management, LLC 300,000$603,0000.15%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$94,3650.00%
OSAIC HOLDINGS, INC. 55$1100.00%
DIMENSIONAL FUND ADVISORS LP 42,514$85,4530.00%
Parallel Advisors, LLC 244$4900.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
WELLS FARGO & COMPANY/MN 75$1510.00%
NORTHERN TRUST CORP 20,982$42,1740.00%
View complete list of ARCA BIOPHARMA INC shareholders